Acute pancreatitis after orthotopic liver transplantation in children
P Tissieres, P Durand, C Chardot, B Dousset, D Debray, F Gauthier, D Devictor – 30 December 2003
Liver transplantation for alcoholic liver disease: Executive statement and recommendations
J H Hoofnagle, T Kresina, R K Fuller, J R Lake, M R Lucey, M F Sorrell, T P Beresford – 30 December 2003
Liver transplantation for end‐stage alcoholic liver disease: An assessment of outcomes
R H Wiesner, M Lombardero, J R Lake, J Everhart, K M Detre – 30 December 2003
Alcoholic liver disease: Natural history
A M Diehl – 30 December 2003
The role of the host immune state in recurrent Hepatitis C
N L Ascher – 30 December 2003
Lower body impedance for the evaluation of venovenous bypass flow
E Ejlersen, P Sode, C Skak, A Rasmussen, K Espersen, P Kirkegaard, N H Secher – 30 December 2003 – Inferior vena cava (IVC) clamping during liver transplantation causes venous congestion in the splanchnic and IVC beds. A venovenous bypass relieves congestion and improves cardiac output (CO), but the bypass flow required for adequate drainage of the vascular beds is controversial. In this study we evaluated the bypass flow necessary to compensate for the IVC clamping. Lower body impedance (BI) is inversely related to tissue fluid content and was used to reflect congestion.
Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: A two‐case report and review
J S Plotkin, J F Buell, M J Njoku, S Wilson, P C Kuo, S T Bartlett, C Howell, L B Johnson – 30 December 2003 – Dapsone, a sulfone antibiotic, has been increasingly used in solid‐organ transplant recipients for the primary prevention of Pneumocystis carinii pneumonia, especially in patients with documented sulfa allergy. A known side effect of dapsone therapy, however, is methemoglobinemia, a condition leading to impaired tissue oxygen delivery.
Liver transplantation from non–heart beating donors in rats: Influence of viscosity and temperature of initial flushing solutions on graft function
T Tojimbara, W N Wicomb, R Garcia‐Kennedy, W Burns, M Hayashi, G Collins, C O Esquivel – 30 December 2003 – Background: We evaluated the effect of warm (37 degrees C) versus cold (4 degrees C) solutions as the initial flush for liver preservation from non‐heart beating donors in rats. Methods: An initial flush was performed just before donor hepatectomy with cold or warm University of Wisconsin solution (UW), UW without hydroxyethyl starch, sodium lactobionate sucrose solution, or lactated Ringer's solution as the control group.
Hepatology highlights
Harvey J. Alter – 30 December 2003